Natasha B. Halasa

Natasha B. Halasa

Auto-generated profile, based on publicly available information

Natasha B. Halasa

Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
NHNatasha B. Halasa
Natasha B. Halasa
SSSadhna M. Shankar
Sadhna M. Shankar
TTThomas R. Talbot
Thomas R. Talbot
PAPatrick G. Arbogast
Patrick G. Arbogast
EME. F. Mitchel
E. F. Mitchel
MGMarie R. Griffin
Marie R. Griffin
Background. We sought to determine the incidence of invasive pneumococcal disease (IPD) among individuals with sickle cell disease (SCD) before and a

1 September 2008 in The Journal of Pediatrics
Verified
Journal Article
Closed access
NHNatasha B. Halasa
Natasha B. Halasa
AOAlice O'SHea
Alice O'SHea
JSJian R. Shi
Jian R. Shi
BLBonnie J LaFleur
Bonnie J LaFleur
KEKathryn M. Edwards
Kathryn M. Edwards

1 August 2021 in Pediatrics
Verified
Journal Article
Closed access
PDF file
ZHZaid Haddadin
Zaid Haddadin
JSJennifer E. Schuster
Jennifer E. Schuster
ASAndrew J. Spieker
Andrew J. Spieker
HRHerdi Rahman
Herdi Rahman
ABAnna Blozinski
Anna Blozinski
NHNatasha B. Halasa
Natasha B. Halasa
OBJECTIVES: Nonpharmaceutical interventions against coronavirus disease 2019 likely have a role in decreasing viral acute respiratory illnesses (ARIs). We aimed to assess the frequency of respiratory syncytial virus (RSV) and influenza ARIs before and during the coronavirus disease 2019 pandemic. METHODS: This study was a prospective, multicenter, population-based ARI surveillance, including children seen in the emergency departments and inpatient settings in 7 US cities for ARI. Respiratory samples were collected and evaluated by molecular testing. Generalized linear mixed-effects models were used to evaluate the association between community mitigation and number of eligible and proportion of RSV and influenza cases. RESULTS: Overall, 45 759 children were eligible; 25 415 were enrolled and tested; 25% and 14% were RSV-positive and influenza-positive, respectively. In 2020, we noted a decrease in eligible and enrolled ARI subjects after community mitigation measures were introduced, with no RSV or influenza detection from April 5, 2020, to April 30, 2020. Compared with 2016–2019, there was an average of 10.6 fewer eligible ARI cases per week per site and 63.9% and 45.8% lower odds of patients testing positive for RSV and influenza, respectively, during the 2020 community mitigation period. In all sites except Seattle, the proportions of positive tests for RSV and influenza in the 2020 community mitigation period were lower than predicted. CONCLUSIONS: Between March and April 2020, rapid declines in ARI cases and the proportions of RSV and influenza in children were consistently noted across 7 US cities, which could be attributable to community mitigation measures against severe acute respiratory syndrome coronavirus 2.

1 February 2023 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
DRDanielle A. Rankin
Danielle A. Rankin
ASAndrew J. Spieker
Andrew J. Spieker
APAriana Perez
Ariana Perez
ASAnna L. Stahl
Anna L. Stahl
HRHerdi K. Rahman
Herdi K. Rahman
CRChelsea Rohlfs
Chelsea Rohlfs
Sharp declines in circulation of enveloped respiratory viruses have been described globally,1-9 including in the US, in temporal association with the COVID-19 pandemic and nonpharmaceutical interventions (eg, masking, social distancing, and handwashing).10-13 Despite these interventions, rhinoviruses (ie, nonenveloped viruses that are sometimes combined with enteroviruses and reported as rhinoviruses and/or enteroviruses because of molecular cross-reactivity between the 2 groups) were not affected as substantially,1-8,10-12 although enterovirus D68 circulation was lower than anticipated in the fall of 2020.14 Continued circulation of rhinoviruses (or rhinovirus and/or enterovirus) has been attributed to viral stability; the possible role of asymptomatic transmission; and/or the relative contribution of different transmission mechanisms, such aerosol, droplet, or contact.1-8,10-12 However, these previous reports describing rhinovirus (or rhinovirus and/or enterovirus) circulation during the pandemic were restricted to the fall of 2020,4,5,7-9 were among heterogeneous populations (unspecific to age group and/or health care setting),4-7,9-12 or had limited clinical descriptions.1-12 Therefore, in this cross-sectional study, we aimed to quantify and characterize rhinovirus and/or enterovirus detection across multiple years before and during the COVID-19 pandemic among children and adolescents seeking medical care for acute respiratory illness (ARI) at emergency departments (EDs) or hospitals within the New Vaccine Surveillance Network (NVSN) in the US.

15 May 2008 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NHNatasha B. Halasa
Natasha B. Halasa
MGMichael A. Gerber
Michael A. Gerber
QCQingxia Chen
Qingxia Chen
PWPeter F. Wright
Peter F. Wright
KEKathryn M. Edwards
Kathryn M. Edwards
Background. Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza h

1 December 2005 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
NHNatasha B. Halasa
Natasha B. Halasa
JWJohn V Williams
John V Williams
GWGregory J. Wilson
Gregory J. Wilson
WWWilliam F. Walsh
William F. Walsh
WSWilliam Schaffner
William Schaffner
PWPeter F. Wright
Peter F. Wright
Respiratory syncytial virus (RSV) causes frequent nosocomial outbreaks in general pediatric wards but is less commonly reported in neonatal intensive care units (NICUs). We investigated an outbreak of RSV infection in a NICU and its impact on health care delivery, outcomes and costs. Retrospective chart review was performed after an RSV outbreak occurred in the NICU. A case was defined as an infant with a nasopharyngeal aspirate positive for RSV by viral culture. Nucleotide sequencing of the isolates was done to determine relatedness. Hospital bills for all RSV culture-positive infants were reviewed. Nine infants (mean age, 34 days; mean birth weight, 1757 g; and mean estimated gestational age 31 weeks and 5 days) were infected with RSV subgroup B during this outbreak. By nucleotide sequencing, the isolates were identical. Clinical manifestations included cough, congestion, increased oxygen requirement, apnea and respiratory failure. The 5 infants requiring intubation had a significantly lower mean birth weight (1301 g versus 2328 g, P = 0.027), mean estimated gestational age (28 weeks and 5 days versus 35 weeks and 2 days, P = 0.014) and mean weight at onset of symptoms (2093 g versus 2989 g, P = 0.049) than the 4 nonintubated infants. More than 1.15 million dollars in hospital charges were attributable to the outbreak. All infants survived. Infants in a NICU who develop cough, congestion or apnea should be tested for RSV and other common respiratory viruses during the winter respiratory season. Even in a closed NICU, nosocomial outbreaks of these viruses can occur and have a major effect on healthcare delivery, costs and outcomes.